Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,252.8
12.1 (0.37%)

 

  • STI Straits Times Index
    3,252.8
    12.1 (0.37%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,608.2
    -1.5 (-0.10%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    26,901.7
    -24.8 (-0.09%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    2,898.0
    -11.9 (-0.41%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    23,370.2
    38.3 (0.16%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,141.1
    -7.6 (-0.12%)
    Index delayed 10 minutes
  • KOR KOSPI
    2,125.2
    1.2 (0.05%)
    Index delayed 20 minutes
  • XAO XAO
    6,847.0
    -30.0 (-0.44%)
     

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 513.5M
  • Value: 379.3M
  • Rise: 134
  • Fall: 94
  • Unch: 600

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Rex Intl0.189-0.010
Golden Agri-Res0.245+0.015
Tritech0.027+0.007
MarcoPolo Marine0.021-0.001
GSS Energy0.105+0.002
Koh Eco0.058+0.001
Alpha Energy0.035-0.001
Ley Choon0.018+0.002
Addvalue Tech0.024+0.001
YZJ Shipbldg SGD0.975-0.005

World Indices

World Indices
Name Last Change
Nasdaq 8,464.3 -11.0
HSI 26,906.5 -20.0
HSCEI 10,626.6 +13.0
Jakarta 6,137.1 -11.7
Nikkei 225 23,370.2 +38.4
SSE Comp 2,893.6 -16.3
Shanghai A 3,031.6 -17.1
Shanghai B 258.0 -1.8
PSE Comp 0.0
KOSPI 2,126.1 +2.0

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

PRESCIENT THERAPEUTICS LIMITED PRESCIENT THERAPEUTICS
Updated on 11 Nov 2019 (End of trading day)
Last (AUD): 0.049 Change: +0.003 High: 0.049 Remarks: -
Change (%): +6.52 Low: 0.048
Open 0.049 Yesterday's Close 0.046
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 474,616 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (AUD) a -0.00963 Trailing EPS (AUD) e -0.00963 NAV (AUD) b 0.0363
PE a - Trailing PE f - Price / NAV b 1.3499
Dividend (AUD) d - Cash In Hand (AUD) g 0.0245 Issued & Paid-up Shares c 394,261,000
Dividend Yield (%) d - Price / Cash In Hand g 2.000 Treasury Shares h -
Beta - 75 Daysi 0.979 R-Squared - 75 Days(%)i 1.92 Market Cap (M) 19.319
Beta - 500 Daysi 0.785 R-Squared - 500 Days (%)i 0.95 Enterprise Value (M) 9.659
Piotroski F Score 2 Exchange Code PTX Par Value ( AUD ) n.a.
52 Weeks Volatility (%) 49.80 Free Float (%) -
Sector & Industry Health Technology - Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 06 May 2019.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 16 Jul 2015.
  9. Beta and R-Squared are calculated in relation to the market index using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference PRESCIENT THERAPEUTICS LIMITED ASX 19.319 - - 1.3499 -
Industry Biotechnology ASX 2,460.725 55.068 54.854 14.4976 0.960
Local Peer CSL ASX 122,798.526 45.770 45.770 16.4100 0.981
Local Peer POLYNOVO LIMITED ASX 1,447.783 - - 55.4430 -
Local Peer AVITA MEDICAL LTD ASX 1,292.287 - - 43.3962 -
Local Peer MESOBLAST LTD ASX 959.722 - - 1.4000 -
Local Peer STARPHARMA HOLDINGS LIMITED ASX 476.145 - - 11.2281 -
Local Peer TELIX PHARMACEUTIC ASX 455.904 - - 10.5510 -
Local Peer NEXT SCIENCE LTD ASX 388.903 - - 11.1798 -
Local Peer NEUREN PHARMACEUTICALS LTD ASX 264.115 85.935 - 15.7442 -
Local Peer RESAPP HEALTH LIMITED ASX 201.914 - - 26.3636 -
Local Peer PHYLOGICA LIMITED ASX 165.626 - - 26.9048 -
Local Peer CYNATA THERAPEUTICS LTD ASX 134.200 - - 12.2306 -
Local Peer ONCOSIL MEDICAL LIMITED ASX 97.760 - - 9.1716 -
Other Local Peers IMUGENE LIMITED (ASX), ORTHOCELL LIMITED (ASX), BIONOMICS LTD (ASX), NOVITA HEALTHCARE LTD (ASX), ACTINOGEN MEDICAL LTD (ASX), BIOTRON (ASX), MEMPHASYS LTD (ASX), RHINOMED LIMITED (ASX), INVEX THERAPEUTICS LTD NPV (ASX), KAZIA THERAPEUTICS LIMITED (ASX), IMMURON LIMITED (ASX), PROTEOMICS INTL LABORATORIES LTD (ASX), REGENEUS LTD (ASX), PATRYS LIMITED (ASX), ALTERITY THERAPEUTICS LIMITED (ASX), ADALTA LTD (ASX), ANTEO DIAGNOSTICS LIMITED (ASX), CONTANGO ASSET MANAGEMENT LIMITED (ASX), CELLMID LIMITED (ASX), NEUROSCIENTIFIC BIOPHARMA LTD (ASX), HOLISTA COLLTECH LIMITED (ASX), CCP TECHNOLOGIES LTD (ASX), GENETIC TECHNOLOGIES (ASX), BENITEC BIOPHARMA LTD (ASX), AUSTRALIAN PRIMARY HEMP LTD (ASX), BIOXYNE LIMITED (ASX), ANATARA LIFESCIENCES LTD (ASX), LIVING CELL TECHNOLOGIES (ASX), IMMUTEP LTD (ASX), MEDIBIO LIMITED (ASX), TBG DIAGNOSTICS LTD (ASX), AVECHO BIOTECHNOLOGY LTD (ASX), NANOLLOSE LTD (ASX), AMPLIA THERAPEUTICS LTD (ASX), BPH ENERGY LIMITED (ASX), FACTOR THERAPEUTICS LIMITED (ASX)
Global Peer AMGEN INC NASDAQ 131,136.409 15.623 16.256 12.0012 2.535
Global Peer GILEAD SCIENCES INC NASDAQ 81,779.296 14.992 30.367 3.9691 3.574
Global Peer CELGENE CORP NASDAQ 77,982.503 19.274 13.262 6.4518 -
Global Peer AMGEN-T HKEx 594,184.000 9.032 9.399 6.9364 4.385
Global Peer BIOGEN INC NASDAQ 53,075.210 11.979 9.837 3.7922 -
Global Peer VERTEX PHARMACEUTICAL NASDAQ 51,918.585 24.766 24.218 9.8829 -
Global Peer ILLUMINA INC NASDAQ 43,365.000 52.500 44.568 9.7691 -
Global Peer REGENERON PHARMACEUTICALS INC NASDAQ 37,800.557 15.464 17.629 3.5985 -
Global Peer ALEXION PHARMACEUTICAL INC NASDAQ 24,122.932 310.862 16.407 2.3269 -
Global Peer AGILENT TECHNOLOGIES INC NYSE 23,782.616 75.261 22.185 5.0100 0.797
Other Global Peers SINO BIOPHARM (HKEx), SEATTLE GENETICS INC (NASDAQ), INCYTE CORPORATION (NASDAQ), WUXI BIO (HKEx), BIOMARIN PHARMACEUTICAL (NASDAQ), BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS (NASDAQ), BEIGENE (HKEx), GALAPAGOS NV SPON ADR REPR 1 ORD SHS (NASDAQ), EXACT SCIENCES CORP (NASDAQ), ALNYLAM PHARMACEUTICALS INC (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), BIO-TECHNE CORP (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), MODERNA INC (NASDAQ), ASCENDIS PHARMA A/S SPON ADR EACH REP 1 ORD SHS (NASDAQ), 10X GENOMICS INC (NASDAQ), EXELIXIS INC (NASDAQ), GENSCRIPT BIO (HKEx), 3SBIO (HKEx), CHINA BIOLOGIC PRODUCTS HLDGS INC (NASDAQ), REPLIGEN CORP (NASDAQ), BLUEBIRD BIO INC (NASDAQ), BIONTECH SE SPON ADS EACH REP 1 ORD SHS (NASDAQ), SPARK THERAPEUTICS INC (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), FIBROGEN INC (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), NEKTAR THERAPEUTICS (NASDAQ), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), IMMUNOMEDICS INC (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), ALKERMES PLC (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), NATERA INC (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), EMERGENT BIOSOLUTIONS INC (NYSE), PTC THERAPEUTICS INC (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), GENOMIC HEALTH INC (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), ACCELERON PHARMA (NASDAQ), UNIQURE N.V. (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), LIGAND PHARMACEUTICAL INC (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), XENCOR INC (NASDAQ), NEXTCURE INC (NASDAQ), AIMMUNE THERAPEUTICS INC (NASDAQ), MYRIAD GENETICS INC (NASDAQ), HAOHAI BIOTEC (HKEx), INSMED INC (NASDAQ), EIDOS THERAPEUTICS INC (NASDAQ), VIELA BIO INC (NASDAQ), MOMENTA PHARMACEUTICALS INC (NASDAQ), VIR BIOTECHNOLOGY INC (NASDAQ), REGENXBIO INC (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), EPIZYME INC (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), AUDENTES THERAPEUTICS INC (NASDAQ), FRONTAGE (HKEx), ENANTA PHARMACEUTICALS INC (NASDAQ), DICERNA PHARMACEUTICALS INC. (NASDAQ), CKLIFE SCIENCES (HKEx), ALECTOR INC (NASDAQ), ZEALAND PHARMA AS SPON ADR EACH REP 1 ORD SHS (NASDAQ), VERACYTE INC (NASDAQ), RADIUS HEALTH INC (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), FATE THERAPEUTICS (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), EDITAS MEDICINE INC (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), OPKO HEALTH INC (NASDAQ), STOKE THERAPEUTICS INC (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), VIVA BIOTECH (HKEx), KARYOPHARM THERAPEUTICS INC (NASDAQ), INTREXON CORP (NASDAQ), AVITA MEDICAL LTD SPON ADS EACH REP 20 ORD SHS (NASDAQ), SPECTRUM PHARMACEUTICALS INC (NASDAQ), ACHILLION PHARMACEUTICALS INC (NASDAQ), ASCENTAGE-B (HKEx), RUBIUS THERAPEUTICS INC (NASDAQ), ARVINAS INC (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), LUMINEX CORP(DEL) (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), KODIAK SCIENCES INC (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), VANDA PHARMACE INC (NASDAQ), TG THERAPEUTICS INC (NASDAQ), IMMUTEP LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), KURA ONCOLOGY INC (NASDAQ), OMEROS CORP (NASDAQ), CORTEXYME INC (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), RAPT THERAPEUTICS INC (NASDAQ), ASCLETIS-B (HKEx), VIKING THERAPEUTICS INC (NASDAQ), CHEMOCENTRYX INC (NASDAQ), TRANSLATE BIO INC (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), RETROPHIN INC (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), MYOVANT SCIENCES LTD (NYSE), PROGENICS PHARMACEUTICALS INC (NASDAQ), SYNTHORX INC (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), HOMOLOGY MEDICINES INC (NASDAQ), IMMUNOGEN INC (NASDAQ), INNATE PHARMA SPON ADS EACH REP 1 ORD SHS (NASDAQ), ESSEX BIO-TECH (HKEx), UROGEN PHARMA LTD (NASDAQ), AGENUS INC (NASDAQ), AVROBIO INC (NASDAQ), CYTOKINETICS INC (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), FREQUENCY THERAPEUTICS INC (NASDAQ), SINOVAC BIOTECH LTD (NASDAQ), MORPHIC HOLDING INC (NASDAQ), PRECISION BIOSCIENCES INC (NASDAQ), XBIOTECH INC (NASDAQ), STEMLINE THERAPEUTICS INC (NASDAQ), DERMIRA INC (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), PREVAIL THERAPEUTICS INC (NASDAQ), CYMABAY THERAPEUTICS INC (NASDAQ), MAGENTA THERAPEUTICS INC (NASDAQ), MACROGENICS INC (NASDAQ), RECRO PHARMA INC (NASDAQ), KADMON HLDGS INC (NYSE), RIGEL PHARMACEUTICALS INC (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), MERUS B V (NASDAQ), ARDELYX INC (NASDAQ), PROTHENA CORP PLC (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), ARCUS BIOSCIENCES INC (NYSE), PUMA BIOTECHNOLOGY INC (NASDAQ), BELLUS HEALTH INC (NASDAQ), LEE'S PHARM (HKEx), CELLULAR BIOMEDICINE GROUP INC (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), MEDICINOVA INC (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), COMPUGEN (NASDAQ), PDL BIOPHARMA INC (NASDAQ), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), PERSONALIS INC (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), RESTORBIO INC (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), GERON CORP (NASDAQ), AVID BIOSERVICES INC (NASDAQ), ANAPTYSBIO INC (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), GLYCOMIMETICS INC (NASDAQ), EIGER BIOPHARMACEUTICALS INC (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), MANNKIND CORPORATION (NASDAQ), SERES THERAPEUTICS (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), APPLIED THERAPEUTICS INC (NASDAQ), PFENEX INC (NYSE American), EVOFEM BIOSCIENCES INC (NASDAQ), REDHILL BIOPHARMA LTD SPON ADS EA REPR 10 ORD ILS0.00 (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), DPHARMA (Bursa), GALECTIN THERAPEUTICS INC (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), CHIASMA INC (NASDAQ), KAMADA (NASDAQ), XOMA CORP (NASDAQ), NEUROINSIGHTS NEUROTECH (NASDAQ), CUE BIOPHARMA INC (NASDAQ), ATHERSYS INC (NASDAQ), PIERIS PHARMACEUTICALS INC (NASDAQ), CABALETTA BIO INC (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), LA JOLLA PHARMACEUTICAL CO (NASDAQ), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), CALITHERA BIOSCIENCES INC (NASDAQ), ELOXX PHARMACEUTICALS INC (NASDAQ), X4 PHARMACEUTICALS INC (NASDAQ), 22ND CENTURY GROUP INC (NYSE American), ALDEYRA THERAPEUTICS (NASDAQ), DYADIC INTERNATIONAL INC (NASDAQ), CONCERT PHARMACEUTICALS INC (NASDAQ), AFFIMED N V (NASDAQ), BBI LIFE SCI (HKEx), NABRIVA THERAPEUTICS PLC (NASDAQ), BICYCLE THERAPEUTICS LTD SPON ADS EACH REP 1 ORD SHS (NASDAQ), IVERIC BIO INC (NASDAQ), ENZO BIOCHEM INC (NYSE), FIVE PRIME THERAPEUTICS (NASDAQ), UNI-BIO GROUP (HKEx), JOUNCE THERAPEUTICS INC (NASDAQ), AXOVANT GENE THERAPIES LTD (NASDAQ), PARATEK PHARMACEUTICALS INC (NASDAQ), APTOSE BIOSCIENCES INC (NASDAQ), IMV INC (NASDAQ), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), NANOVIRICIDES INC (NYSE American), EDAP TMS S.A. SPON ADR EACH REPR 1 ORD SHARE (NASDAQ), NAVIDEA BIOPHARMACEUTICALS INC (NYSE American), TRACON PHARMACEUTICALS INC (NASDAQ), PALATIN TECHNOLOGIES INC (NYSE American), LINEAGE CELL THERAPEUTICS INC (NYSE American), T2 BIOSYSTEMS INC (NASDAQ), SESEN BIO INC (NASDAQ), ACORDA THERAPEUTICS INC (NASDAQ), AVALON GLOBOCARE CORP (NASDAQ), NANTKWEST INC (NASDAQ), NOVAVAX INC (NASDAQ), HARVARD BIOSCIENCE INC (NASDAQ), AXCELLA HEALTH INC (NASDAQ), FENNEC PHARMACEUTICALS INC (NASDAQ), CHIMERIX INC (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), VBI VACCINES INC CDA (NASDAQ), CORREVIO PHARMA CORP (NASDAQ), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), ADURO BIOTECH INC (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC ADS EACH REPR 6 SHS (SPONS) (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), BRAINSTROM CELL THERAPEUTICS (NASDAQ), MATINAS BIOPHARMA HOLDINGS INC (NYSE American), AVEO PHARMACEUTICALS INC (NASDAQ), COHBAR INC (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), VERASTEM INC (NASDAQ), VACCINEX INC (NASDAQ), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), ANIXA BIOSCIENCES INC (NASDAQ), OTONOMY INC (NASDAQ), ARAVIVE INC (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), SYNLOGIC INC (NASDAQ), INFLARX N V (NASDAQ), TREVENA INC (NASDAQ), IDERA PHARMACEUTICALS INC (NASDAQ), CATALYST BIOSCIENCES INC (NASDAQ), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), CEL-SCI CORP (NYSE American), OPIANT PHARMACEUTICALS INC (NASDAQ), CIDARA THERAPEUTICS INC (NASDAQ), SELECTA BIOSCIENCES INC (NASDAQ), CHAMPIONS ONCOLOGY INC (NASDAQ), VERMILLION INC (NASDAQ), CATABASIS PHARMACEUTICALS INC (NASDAQ), GENOCEA BIOSCIENCES INC (NASDAQ), ORGENESIS INC (NASDAQ), EQUILLIUM INC (NASDAQ), NEWLINK GENETICS CORP (NASDAQ), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), NEON THERAPEUTICS INC (NASDAQ), SYNTHETIC BIOLOGICS INC (NYSE American), INFINITY PHARMACEUTICALS INC (NASDAQ), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), SUMMIT THERAPEUTICS PLC ADS EACH REPR 5 ORD (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), SUNESIS PHARMACEUTICALS INC (NASDAQ), MERRIMACK PHARMACEUTICALS INC (NASDAQ), PLURISTEM THERAPEUTICS INC (NASDAQ), ORGANOVO HLDGS INC (NASDAQ), CT ENTERPRISE (HKEx), CURIS INC (NASDAQ), INMUNE BIO INC (NASDAQ), PORT (SET), SURFACE ONCOLOGY INC (NASDAQ), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), BELLICUM PHARMACEUTICALS (NASDAQ), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), VISTAGEN THERAPEUTICS INC (NASDAQ), VASCULAR BIOGENICS LTD (NASDAQ), PROTEOSTASIS THERAPEUTICS INC (NASDAQ), ARMATA PHARMACEUTICALS INC (NYSE American), FORWARD PHARMA AS SPON ADS EACH REP 2 ORD SHS (NASDAQ), EVOGENE LTD (NASDAQ), UNUM THERAPEUTICS INC (NASDAQ), DIAMEDICA THERAPEUTICS INC (NASDAQ), ITERUM THERAPEUTICS PLC (NASDAQ), CELLDEX THERAPEUTICS INC (NASDAQ), OUTLOOK THERAPEUTICS INC (NASDAQ), SAVARA INC (NASDAQ), REGENT PACIFIC (HKEx), LEAP THERAPEUTICS INC (NASDAQ), BIO-PATH HOLDINGS INC (NASDAQ), INNOVATE BIOPHARMACEUTICALS INC (NASDAQ), APTEVO THERAPEUTICS INC (NASDAQ), BIOCARDIA INC (NASDAQ), FIBROCELL SCIENCE INC (NASDAQ), ZAFGEN INC (NASDAQ), INDIA GLOBALIZATION CAPITAL INC (NYSE American), ONCOLYTICS BIOTECH INC (NASDAQ), CONTRAFECT CORP (NASDAQ), BIOSINO BIO-TEC (HKEx), EXTRAWELL PHAR (HKEx), ORAGENICS INC (NYSE American), MIRAGEN THERAPEUTICS INC (NASDAQ), SEELOS THERAPEUTICS INC (NASDAQ), SOLIGENIX INC (NASDAQ), MICROBOT MEDICAL INC (NASDAQ), AETERNA ZENTARIS INC (NASDAQ), ACTINIUM PHARMACEUTICALS INC (NYSE American), SIERRA ONCOLOGY INC (NASDAQ), MIDATECH PHARMA PLC SPON ADS EACH REP 20 ORD SHS(R/S) (NASDAQ), SENESTECH INC (NASDAQ), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), BIONANO GENOMICS INC (NASDAQ), ISORAY INC (NYSE American), ALIMERA SCIENCES INC (NASDAQ), ANCHIANO THERAPEUTICS LTD SPON ADS EACH REP 5 ORD SHS (NASDAQ), AZURRX BIOPHARMA INC (NASDAQ), IMMURON LIMITED SPON ADR EACH REPR 40 ORD SHS (NASDAQ), HEAT BIOLOGICS INC (NASDAQ), AEVI GENOMIC MEDIC (NASDAQ), SOPHIRIS BIO INC (NASDAQ), CO DIAGNOSTICS INC (NASDAQ), PULMATRIX INCORPORATED (NASDAQ), BIOCEPT INC (NASDAQ), TOCAGEN INC (NASDAQ), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), PRECIPIO INC (NASDAQ), ATYR PHARMA INC (NASDAQ), IBIO INC (NYSE American), DARE BIOSCIENCE INC (NASDAQ), TROVAGENE INC (NASDAQ), VAXART INC (NASDAQ), CELLECTAR BIOSCIENCES INC (NASDAQ), CONATUS PHARMACEUTICALS INC (NASDAQ), OCUGEN INC (NASDAQ), BENITEC BIOPHARMA LTD SPON ADS EA REPR 20 ORD SHS (NASDAQ), GENETIC TECHNOLOGIES SPON ADS EA REP 600 ORD SHS(R/S) (NASDAQ), MEGASUN (Bursa), NOVABAY PHARMACEUTICALS INC (NYSE American), HAO WEN HLDGS (HKEx), ADVAXIS INC (NASDAQ), CAPRICOR THERAPEUTICS INC (NASDAQ), ARCA BIOPHARMA INC (NASDAQ), CAN FITE BIOPHARMA LTD SPON ADS EA REP 30 ORD SHS(POST REV SPL (NYSE American), ENDRA LIFE SCIENCES INC (NASDAQ), XENETIC BIOSCIENCES INC (NASDAQ), ACHIEVE LIFE SCIENCE INC (NASDAQ), MGRC (Bursa), CLEVELAND BIOLABS INC (NASDAQ), REXAHN PHARMACEUTICALS INC (NASDAQ), XTL BIOPHARMACEUTICALS LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), TRILLIUM THERAPEUTICS INC (NASDAQ), CYCLACEL PHARMA IN (NASDAQ), PHIO PHARMACEUTICALS CORP (NASDAQ), THERAPIX BIOSCIENCES LTD SPON ADR EACH REP 40 ORD (POST SPLIT) (NASDAQ), AIM IMMUNOTECH INC (NYSE American), PROTEON THERAPEUTICS INC (NASDAQ), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ), ONCONOVA THERAPEUTICS INC (NASDAQ), AURIS MEDICAL HOLDING LTD (NASDAQ), DIFFUSION PHARMACEUTICALS INC (NASDAQ), SENECA BIOPHARMA INC (NASDAQ), CELLECT BIOTECHNOLOGY LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), SPHERIX INC (NASDAQ), MOTIF BIO PLC ADR EACH REPR 20 SHS SPON (NASDAQ), PLUS THERAPEUTICS INC (NASDAQ), OPGEN INC (NASDAQ)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --0.001
-2.00 %
10 Days --0.011
-18.33 %
20 Days --0.003
-5.77 %
Medium Term Return 3 Months -+0.006
+13.95 %
6 Months -+0.008
+19.51 %
1 Year --0.037
-43.02 %
Long Term Return 2 Years --0.018
-26.87 %
3 Years --0.049
-50.00 %
5 Years --0.123
-71.51 %
Annualised Return Annualised --
-22.21 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 0.037 - 0.098 Change From 1 Year Low +0.012 % Change From 1 Year Low (%) +32.43
Change From 1 Year High -0.049 % Change From 1 Year High (%) -50.10
2 Years Range 0.037 - 0.177 Change From 2 Years Low +0.012 % Change From 2 Years Low (%) +32.43
Change From 2 Years High -0.128 % Change From 2 Years High (%) -72.29
5 Years Range 0.037 - 0.177 Change From 5 Years Low +0.012 % Change From 5 Years Low (%) +32.43
Change From 5 Years High -0.128 % Change From 5 Years High (%) -72.29
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Prescient Therapeutics Ltd. is a biopharmaceutical company, which engages in the discovery and development of novel immunotherapeutic products for the treatment of chronic infectious diseases and cancer. It develops immune therapeutics based upon its Co-X-Gene and fowlpox virus delivery technologies. The company was founded May 22, 1986 and is headquartered in Perth, Australia.

Historical Price Data

Date Open High Low Close Volume VWAP
11 Nov 2019 0.049 0.049 0.048 0.049 474,616 -
08 Nov 2019 0.046 0.048 0.044 0.046 1,826,334 -
07 Nov 2019 0.046 0.047 0.044 0.044 1,236,518 -
06 Nov 2019 0.047 0.049 0.045 0.047 1,441,355 -
05 Nov 2019 0.050 0.050 0.044 0.045 3,406,138 -
04 Nov 2019 0.049 0.052 0.047 0.050 3,603,228 -
01 Nov 2019 0.057 0.058 0.043 0.048 6,414,870 -
31 Oct 2019 0.058 0.061 0.057 0.057 2,395,770 -
30 Oct 2019 0.056 0.057 0.054 0.056 2,628,438 -
29 Oct 2019 0.059 0.059 0.056 0.058 1,923,304 -
28 Oct 2019 0.058 0.064 0.057 0.060 1,963,117 -
25 Oct 2019 0.056 0.058 0.056 0.057 906,915 -
24 Oct 2019 0.059 0.059 0.055 0.056 1,498,564 -
23 Oct 2019 0.062 0.063 0.056 0.057 1,841,341 -
22 Oct 2019 0.057 0.061 0.057 0.061 3,331,234 -
21 Oct 2019 0.056 0.058 0.055 0.056 1,048,877 -
18 Oct 2019 0.056 0.058 0.054 0.054 453,965 -
17 Oct 2019 0.057 0.057 0.054 0.056 332,168 -
16 Oct 2019 0.054 0.056 0.054 0.056 935,652 -
15 Oct 2019 0.053 0.054 0.051 0.054 952,351 -
14 Oct 2019 0.054 0.054 0.052 0.052 1,409,418 -
11 Oct 2019 0.056 0.056 0.053 0.054 1,855,508 -
Summary
Current 2 Weeks
(29 Oct 2019 to 11 Nov 2019)
0.059 0.061 0.043 0.049 25,350,571 -
Previous 2 Weeks
(15 Oct 2019 to 28 Oct 2019)
0.053 0.061 0.043 0.060 13,264,184 -
4 Weeks from
(17 Sep 2019 to 14 Oct 2019)
0.057 0.061 0.043 0.052 38,227,645 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.